AMBALAL SARABHAI ENT L (AMBALALSA) financials

AMBALAL SARABHAI ENT L (AMBALALSA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1977, Ambalal Sarabhai Enterprises Ltd is in the business of manufacturing Pharmaceuticals and Electronics[1]

Market Cap: ₹295Cr.
Current Price: ₹38.5
Stock P/E: 71.3
ROE: 20.4%
ROCE: 16.4%
Book Value: ₹7.76
Dividend Yield: 0.00%
52W High / Low: ₹50.0/23.1

In Jun 2026, AMBALAL SARABHAI ENT L (AMBALALSA) reported sales ₹0.54 Cr and net profit ₹0.03 Cr.

Annual TTM: sales ₹2.85 Cr, net profit ₹4.14 Cr.

Shareholding: Promoters 31.36% (Sep 2026), FIIs 0.00% (Sep 2026), DIIs 0.00% (Sep 2026), Public 68.62% (Sep 2026), No. of Shareholders 1,66,230% (Sep 2026).

AMBALALSA quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	0.00	1.17	1.73	1.64	0.79	0.00	1.52	0.54
Expenses	1.80	3.74	3.43	2.83	2.43	0.94	2.88	1.76
Operating Profit	-1.80	-2.57	-1.70	-1.19	-1.64	-0.94	-1.36	-1.22
OPM %	—	-219.66%	-98.27%	-72.56%	-207.59%	—	-89.47%	-225.93%
Other Income	6.37	10.81	-3.21	8.17	1.36	2.89	3.16	1.70
Interest	0.09	0.10	0.05	0.07	0.08	0.09	0.17	0.17
Depreciation	0.03	0.02	0.02	0.02	0.02	0.02	0.02	0.02
Profit before tax	4.45	8.12	-4.98	6.89	-0.38	1.84	1.61	0.29
Tax %	3.15%	-3.82%	-0.40%	0.00%	0.00%	-0.54%	-64.60%	89.66%
Net Profit	4.31	8.43	-4.96	6.88	-0.38	1.84	2.65	0.03
EPS in Rs	0.56	1.10	-0.65	0.90	-0.05	0.24	0.35	0.00
Raw PDF	—	—	—	—	—	—	—	—

AMBALALSA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0.00	0.00	0.13	3.71	3.81	4.04	3.94	2.85
Expenses	7.86	11.69	5.71	8.87	8.61	11.37	9.06	8.01
Operating Profit	-7.86	-11.69	-5.58	-5.16	-4.80	-7.33	-5.12	-5.16
OPM %	—	—	-4,292.31%	-139.08%	-125.98%	-181.44%	-129.95%	-181.05%
Other Income	24.61	3.16	9.47	9.75	7.89	15.85	15.57	9.11
Interest	0.46	0.56	0.25	0.11	2.16	0.34	0.41	0.51
Depreciation	0.39	0.38	0.19	0.15	0.12	0.10	0.09	0.08
Profit before tax	15.90	-9.47	3.45	4.33	0.81	8.08	9.95	3.36
Tax %	2.20%	-0.84%	14.49%	5.31%	-217.28%	-1.98%	-10.45%	—
Net Profit	15.55	-9.39	2.96	4.11	2.58	8.24	10.99	4.14
EPS in Rs	2.03	-1.23	0.39	0.54	0.34	1.08	1.43	0.54
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

AMBALALSA balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	76.63	76.63	76.63	76.63	76.63	76.63	76.63	76.63
Reserves	-51.85	-36.39	-45.85	-42.93	-38.79	-36.34	-28.14	-17.15
Borrowings	11.07	11.00	11.14	9.77	11.49	10.03	7.66	11.00
Other Liabilities	102.78	73.35	58.14	39.53	30.42	30.96	26.77	15.31
Total Liabilities	138.63	124.59	100.06	83.00	79.75	81.28	82.92	85.79
Fixed Assets	14.65	14.48	13.97	13.00	12.86	12.84	12.22	12.13
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	55.97	56.43	26.58	25.54	25.54	25.39	25.34	25.34
Other Assets	68.01	53.68	59.51	44.46	41.35	43.05	45.36	48.32
Total Assets	138.63	124.59	100.06	83.00	79.75	81.28	82.92	85.79

AMBALALSA cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-3.27	-4.53	-10.42	-7.79	1.52	-3.82	-4.08	-0.26
Cash from Investing Activity	2.37	4.92	15.76	20.77	0.61	3.48	6.35	-3.02
Cash from Financing Activity	-0.44	-0.42	-0.32	-16.46	-3.76	0.30	-2.31	3.40
Net Cash Flow	-1.33	-0.03	5.02	-3.47	-1.63	-0.04	-0.04	0.11
Free Cash Flow	-3.33	-4.50	0.66	11.47	1.58	-3.91	1.11	-0.27
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	-11%	51%	85%	128%	-45%	65%	47%	61%

AMBALALSA shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	31.35%	31.35%	31.35%	31.35%	31.36%	31.36%	31.36%	31.36%
FIIs	0.00%	0.38%	0.38%	0.34%	0.34%	0.00%	0.00%	0.00%
DIIs	0.10%	0.10%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	68.54%	68.18%	68.26%	68.32%	68.29%	68.64%	68.64%	68.62%
No. of Shareholders	1,71,221	1,70,912	1,69,630	1,70,015	1,68,396	1,67,599	1,67,066	1,66,230

AMBALALSA key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	—	—	—	421.15	29.51	37.36	37.04	38.91
Inventory Days	—	—	—	0.00	2.01	0.00	0.00	6.62
Days Payable	—	—	—	—	1,611.83	—	—	712.03
Cash Conversion Cycle	—	—	—	421.15	-1,580.31	37.36	37.04	-666.51
Working Capital Days	—	—	—	-30,660.00	-1,037.94	-686.89	109.32	1,379.40
ROCE %	-7.41%	36.90%	-4.27%	9.93%	11.12%	5.96%	6.01%	16.36%

AMBALALSAUpdated 20 Oct 2026, 6:16

Ambalal Sarabhai Ent L

AMBALALSAUpdated 20 Oct 2026, 6:16

Market Cap

₹295Cr.

Current Price

₹38.5

High / Low

₹50.0/23.1

Stock P/E

71.3

ROE20.4%

ROCE16.4%

Book Value₹7.76

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1977, Ambalal Sarabhai Enterprises Ltd is in the business of manufacturing Pharmaceuticals and Electronics[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	1.7	0.03	4.84	1.18	0.03	-2.02	0	-2.02	-0.26
Sep 2023	0.8	0.04	2.13	1.96	0.03	0.56	0	0.56	0.07
Dec 2023	0.33	0.06	1.96	1.33	0.03	-0.39	69.23	-0.65	-0.08
Mar 2024	0.99	0.07	1.64	3.41	0.03	2.66	-76.32	4.7	0.61
Jun 2024	1.14	0.09	2.41	1.88	0.03	0.49	6.12	0.46	0.06
Sep 2024	0	0.09	1.8	6.37	0.03	4.45	3.15	4.31	0.56
Dec 2024	1.17	0.1	3.74	10.81	0.02	8.12	-3.82	8.43	1.1
Mar 2025	1.73	0.05	3.43	-3.21	0.02	-4.98	-0.4	-4.96	-0.65
Jun 2025	1.64	0.07	2.83	8.17	0.02	6.89	0	6.88	0.9
Sep 2025	0.79	0.08	2.43	1.36	0.02	-0.38	0	-0.38	-0.05
Dec 2025	0	0.09	0.94	2.89	0.02	1.84	-0.54	1.84	0.24
Mar 2026	1.52	0.17	2.88	3.16	0.02	1.61	-64.6	2.65	0.35
Jun 2026	0.54	0.17	1.76	1.7	0.02	0.29	89.66	0.03	0

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	15.25	7.91	27.3	14.17	3.36	-9.15	0	-9.15	-1.19
Mar 2016	6.98	1.99	28.62	95.94	14.62	57.69	20.8	45.68	5.96
Mar 2017	1.51	2.62	14.47	-0.63	2.45	-18.66	10.18	-20.57	-2.68
Mar 2018	0.92	1.05	21.76	24.49	0.42	2.18	166.06	-1.44	-0.19
Mar 2019	0	0.62	8.86	6.46	0.4	-3.42	13.45	-3.88	-0.51
Mar 2020	0	0.46	7.86	24.61	0.39	15.9	2.2	15.55	2.03
Mar 2021	0	0.56	11.69	3.16	0.38	-9.47	-0.84	-9.39	-1.23
Mar 2022	0.13	0.25	5.71	9.47	0.19	3.45	14.49	2.96	0.39
Mar 2023	3.71	0.11	8.87	9.75	0.15	4.33	5.31	4.11	0.54
Mar 2024	3.81	2.16	8.61	7.89	0.12	0.81	-217.28	2.58	0.34
Mar 2025	4.04	0.34	11.37	15.85	0.1	8.08	-1.98	8.24	1.08
Mar 2026	3.94	0.41	9.06	15.57	0.09	9.95	-10.45	10.99	1.43
TTM	2.85	0.51	8.01	9.11	0.08	3.36	—	4.14	0.54

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	31.36%
Public	68.62%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	30.78%	0%	0%	69.21%
Mar 2024	30.78%	0%	0%	69.23%
Jun 2024	30.78%	0%	0%	69.22%
Sep 2024	31.35%	0%	0%	68.65%
Dec 2024	31.35%	0%	0.1%	68.54%
Mar 2025	31.35%	0.38%	0.1%	68.18%
Jun 2025	31.35%	0.38%	0%	68.26%
Sep 2025	31.35%	0.34%	0%	68.32%
Dec 2025	31.36%	0.34%	0%	68.29%
Mar 2026	31.36%	0%	0%	68.64%
Jun 2026	31.36%	0%	0%	68.64%
Sep 2026	31.36%	0%	0%	68.62%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	76.63	-73.49	30.1	103.24	136.48	42.66	0.1	56.29	37.43	136.48
Mar 2016	76.63	-27.8	29.54	65.13	143.5	20.6	0	82.91	39.99	143.5
Mar 2017	76.63	-46.41	22.13	63.81	116.16	16.43	0	76.19	23.54	116.16
Mar 2018	76.63	-47.98	11.07	91.28	131	14.98	0	55.88	60.14	131
Mar 2019	76.63	-51.85	11.07	102.78	138.63	14.65	0	55.97	68.01	138.63
Mar 2020	76.63	-36.39	11	73.35	124.59	14.48	0	56.43	53.68	124.59
Mar 2021	76.63	-45.85	11.14	58.14	100.06	13.97	0	26.58	59.51	100.06
Mar 2022	76.63	-42.93	9.77	39.53	83	13	0	25.54	44.46	83
Mar 2023	76.63	-38.79	11.49	30.42	79.75	12.86	0	25.54	41.35	79.75
Mar 2024	76.63	-36.34	10.03	30.96	81.28	12.84	0	25.39	43.05	81.28
Mar 2025	76.63	-28.14	7.66	26.77	82.92	12.22	0	25.34	45.36	82.92
Mar 2026	76.63	-17.15	11	15.31	85.79	12.13	0	25.34	48.32	85.79

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	-12.05	12.7	-0.75	-0.1
Mar 2016	-69.37	75.22	-2.56	3.3
Mar 2017	-3.67	8.64	-8.14	-3.17
Mar 2018	-12.66	26.14	-12.15	1.33
Mar 2019	-3.27	2.37	-0.44	-1.33
Mar 2020	-4.53	4.92	-0.42	-0.03
Mar 2021	-10.42	15.76	-0.32	5.02
Mar 2022	-7.79	20.77	-16.46	-3.47
Mar 2023	1.52	0.61	-3.76	-1.63
Mar 2024	-3.82	3.48	0.3	-0.04
Mar 2025	-4.08	6.35	-2.31	-0.04
Mar 2026	-0.26	-3.02	3.4	0.11

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	37.34	1.57	0.00	0.00	—	—	—	421.15	29.51	37.36	37.04	38.91
Inventory Days	76.36	22.52	47.93	56.64	—	—	—	0.00	2.01	0.00	0.00	6.62
Days Payable	320.68	729.22	3,974.44	13,253.28	—	—	—	—	1,611.83	—	—	712.03
Cash Conversion Cycle	-206.97	-705.13	-3,926.52	-13,196.64	—	—	—	421.15	-1,580.31	37.36	37.04	-666.51
Working Capital Days	-2,355.15	-3,035.57	-16,105.93	-23,784.51	—	—	—	-30,660.00	-1,037.94	-686.89	109.32	1,379.40
ROCE %	-34.09%	-59.62%	-12.82%	-21.98%	-7.41%	36.90%	-4.27%	9.93%	11.12%	5.96%	6.01%	16.36%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of AMBALAL SARABHAI ENT L (AMBALALSA)?

The reported market capitalisation for AMBALAL SARABHAI ENT L (AMBALALSA) is ₹295Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of AMBALALSA?

The current price shown for AMBALAL SARABHAI ENT L (AMBALALSA) on Fincrux is ₹38.5 with a 52-week high/low of ₹50.0/23.1.

What is the P/E ratio of AMBALAL SARABHAI ENT L (AMBALALSA)?

The stock P/E for AMBALAL SARABHAI ENT L (AMBALALSA) is 71.3 on Fincrux, with ROE at 20.4% and ROCE at 16.4%.

What were AMBALALSA latest quarterly results?

For Jun 2026, AMBALAL SARABHAI ENT L (AMBALALSA) reported sales ₹0.54 Cr and net profit ₹0.03 Cr (figures in ₹ crore unless noted).

What are AMBALALSA annual sales and net profit?

For TTM, AMBALAL SARABHAI ENT L (AMBALALSA) shows sales of ₹2.85 Cr and net profit of ₹4.14 Cr on the Fincrux profit & loss statement.

Who owns AMBALAL SARABHAI ENT L (AMBALALSA)?

Latest shareholding for AMBALAL SARABHAI ENT L (AMBALALSA) on Fincrux: Promoters 31.36% (Sep 2026), FIIs 0.00% (Sep 2026), DIIs 0.00% (Sep 2026), Public 68.62% (Sep 2026), No. of Shareholders 1,66,230% (Sep 2026).

Where can I find AMBALAL SARABHAI ENT L (AMBALALSA) financials?

AMBALAL SARABHAI ENT L (AMBALALSA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show AMBALALSA balance sheet and cash flow?

Yes. The AMBALAL SARABHAI ENT L (AMBALALSA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 20 October 2026 at 6:16